Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Diabetes Research, enter your email address in the box below.

Journal of Diabetes Research
Volume 2017, Article ID 4727942, 10 pages
https://doi.org/10.1155/2017/4727942
Research Article

Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy

Qiaoyun Gong, Jia’nan Xie, Yang Liu, Ying Li, and Guanfang Su

Eye Center, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun, Jilin 130021, China

Correspondence should be addressed to Guanfang Su; moc.361@2102fgus

Received 25 April 2017; Revised 21 May 2017; Accepted 22 May 2017; Published 15 June 2017

Academic Editor: Patrizio Tatti

Copyright © 2017 Qiaoyun Gong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Antonetti, R. Klein, and T. W. Gardner, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 366, pp. 1227–1239, 2012. View at Google Scholar
  2. B. A. Mysona, S. Matragoon, M. Stephens et al., “Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy,” BioMed Research International, vol. 2015, Article ID 571456, 12 pages, 2015. View at Google Scholar
  3. T. W. Gardner, D. A. Antonetti, A. J. Barber, K. F. LaNoue, and S. W. Levison, “Diabetic retinopathy: more than meets the eye,” Survey of Ophthalmology, vol. 47, Supplement 2, pp. S253–S262, 2002. View at Google Scholar
  4. J. G. Cunha-Vaz and A. Travassos, “Breakdown of the blood-retinal barriers and cystoid macular edema,” Survey of Ophthalmology, vol. 28, no. Suppl, pp. 485–492, 1984. View at Google Scholar
  5. T. A. Ciulla, A. G. Amador, and B. Zinman, “Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies,” Diabetes Care, vol. 26, pp. 2653–2664, 2003. View at Google Scholar
  6. N. Miyamoto, Y. de Kozak, J. C. Jeanny et al., “Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy,” Diabetologia, vol. 50, pp. 461–470, 2007. View at Google Scholar
  7. O. Strauss, “The retinal pigment epithelium in visual function,” Physiological Reviews, vol. 85, pp. 845–881, 2005. View at Google Scholar
  8. D. Aronson and E. J. Rayfield, “How hyperglycemia promotes atherosclerosis: molecular mechanisms,” Cardiovascular Diabetology, vol. 1, p. 1, 2002. View at Google Scholar
  9. R. N. Frank, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 350, pp. 48–58, 2004. View at Google Scholar
  10. R. Mastropasqua, L. Toto, F. Cipollone, D. Santovito, P. Carpineto, and L. Mastropasqua, “Role of microRNAs in the modulation of diabetic retinopathy,” Progress in Retinal and eye Research, vol. 43, pp. 92–107, 2014. View at Google Scholar
  11. J. H. Wu, Y. Gao, A. J. Ren et al., “Altered microRNA expression profiles in retinas with diabetic retinopathy,” Ophthalmic Research, vol. 47, pp. 195–201, 2012. View at Google Scholar
  12. B. Yan, Z. F. Tao, X. M. Li, H. Zhang, J. Yao, and Q. Jiang, “Aberrant expression of long noncoding RNAs in early diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 55, pp. 941–951, 2014. View at Google Scholar
  13. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, pp. 281–297, 2004. View at Google Scholar
  14. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, pp. 215–233, 2009. View at Google Scholar
  15. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews. Genetics, vol. 11, pp. 597–610, 2010. View at Google Scholar
  16. Y. Mitamura, C. Harada, and T. Harada, “Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathy,” Current Diabetes Reviews, vol. 1, pp. 73–81, 2005. View at Google Scholar
  17. A. Arora, J. Guduric-Fuchs, L. Harwood, M. Dellett, T. Cogliati, and D. A. Simpson, “Prediction of microRNAs affecting mRNA expression during retinal development,” BMC Developmental Biology, vol. 10, p. 1, 2010. View at Google Scholar
  18. R. K. Kutty, W. Samuel, C. Jaworski et al., “MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide,” Molecular Vision, vol. 16, pp. 1475–1486, 2010. View at Google Scholar
  19. X. Liu, J. Xie, Z. Liu, Q. Gong, R. Tian, and G. Su, “Identification and validation of reference genes for quantitative RT-PCR analysis of retinal pigment epithelium cells under hypoxia and/or hyperglycemia,” Gene, vol. 580, pp. 41–46, 2016. View at Google Scholar
  20. J. Xie, X. Liu, Y. Li, Y. Liu, and G. Su, “Validation of RT-qPCR reference genes and determination of Robo4 expression levels in human retinal endothelial cells under hypoxia and/or hyperglycemia,” Gene, vol. 585, pp. 135–142, 2016. View at Google Scholar
  21. C. K. Kramer, T. C. Rodrigues, L. H. Canani, J. L. Gross, and M. J. Azevedo, “Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies,” Diabetes Care, vol. 34, pp. 1238–1244, 2011. View at Google Scholar
  22. S. Saker, E. A. Stewart, A. C. Browning, C. L. Allen, and W. M. Amoaku, “The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells,” Experimental eye Research, vol. 121, pp. 161–167, 2014. View at Google Scholar
  23. L. Wang, J. Wang, J. Fang, H. Zhou, X. Liu, and S. B. Su, “High glucose induces and activates toll-like receptor 4 in endothelial cells of diabetic retinopathy,” Diabetology & Metabolic Syndrome, vol. 7, p. 89, 2015. View at Google Scholar
  24. C. M. Sena, A. M. Pereira, and R. Seica, “Endothelial dysfunction - a major mediator of diabetic vascular disease,” Biochimica et Biophysica Acta, vol. 1832, pp. 2216–2231, 2013. View at Google Scholar
  25. M. V. Joglekar, A. S. Januszewski, A. J. Jenkins, and A. A. Hardikar, “Circulating microRNA biomarkers of diabetic retinopathy,” Diabetes, vol. 65, pp. 22–24, 2016. View at Google Scholar
  26. B. Feng, S. Chen, K. McArthur et al., “miR-146a-mediated extracellular matrix protein production in chronic diabetes complications,” Diabetes, vol. 60, pp. 2975–2984, 2011. View at Google Scholar
  27. B. Kovacs, S. Lumayag, C. Cowan, and S. Xu, “MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats,” Investigative Ophthalmology & Visual Science, vol. 52, pp. 4402–4409, 2011. View at Google Scholar
  28. D. Deng, L. Wang, Y. Chen et al., “MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma,” Cancer Science, vol. 107, pp. 899–907, 2016. View at Google Scholar
  29. S. Liu, C. Hu, Y. Wang, G. Shi, Y. Li, and H. Wu, “miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3,” Oncology Reports, vol. 36, pp. 2398–2404, 2016. View at Google Scholar
  30. Q. Yuan, T. Sun, F. Ye, W. Kong, and H. Jin, “MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA,” Cancer Biomarkers, vol. 19, pp. 93–101, 2017. View at Google Scholar
  31. K. Lee and L. R. Ferguson, “MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer,” World Journal of Gastroenterology, vol. 22, pp. 7389–7401, 2016. View at Google Scholar
  32. Y. He, J. Wang, J. Wang et al., “MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2,” American Journal of Cancer Research, vol. 5, pp. 1382–1395, 2015. View at Google Scholar
  33. C. Chakraborty, C. G. Doss, S. Bandyopadhyay, and G. Agoramoorthy, “Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes,” Wiley Interdisciplinary Reviews RNA, vol. 5, pp. 697–712, 2014. View at Google Scholar
  34. S. Ling, Y. Birnbaum, M. K. Nanhwan, B. Thomas, M. Bajaj, and Y. Ye, “MicroRNA-dependent cross-talk between VEGF and HIF1alpha in the diabetic retina,” Cellular Signalling, vol. 25, pp. 2840–2847, 2013. View at Google Scholar
  35. S. Safe, “MicroRNA-specificity protein (Sp) transcription factor interactions and significance in carcinogenesis,” Current Pharmacology Reports, vol. 1, pp. 73–78, 2015. View at Google Scholar
  36. G. Zhang, H. Shi, L. Wang et al., “MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction,” PloS One, vol. 10, article e0135339, 2015. View at Google Scholar
  37. N. Yoshida-Hata, Y. Mitamura, T. Oshitari et al., “Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy,” Diabetes Research and Clinical Practice, vol. 87, pp. e26–e28, 2010. View at Google Scholar
  38. K. Donovan, O. Alekseev, X. Qi, W. Cho, and J. Azizkhan-Clifford, “O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells,” Investigative Ophthalmology & Visual Science, vol. 55, pp. 7862–7873, 2014. View at Google Scholar